Point72 Hong Kong’s Korro Bio KRRO Stock Holding History

Point72 Hong Kong’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-45	Closed	-$5K	–	2186
2022 Q1	$5K	Buy	+45	New	+$8.6K	﹤0.01%	1680

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's KRRO Position: Q2 2022 in Review

Point72 Hong Kong sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 45 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in KRRO in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

Point72 Hong Kong reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 45 Korro Bio shares in Q2 2022, an estimated $5K.
Point72 Hong Kong first reported a position in Korro Bio in Q1 2022 and held it in 1 quarter.
Point72 Hong Kong's Korro Bio position peaked at $5K in Q1 2022.
58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.